Prognostic value of a whole body FDG PET vs conventional imaging for the evaluation of biologic therapy in renal cell carcinoma.

被引：0
|
作者：
Hoh, CK [1 ]
Figlin, RA [1 ]
Seltzer, MA [1 ]
Belldegrun, A [1 ]
Franklin, J [1 ]
Gitliz, B [1 ]
Phelps, ME [1 ]
Maddahi, J [1 ]
机构：
[1] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1997年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：546 / 546
页数：1
相关论文
共 50 条
  • [1] Evaluation of renal cell carcinoma with whole body FDG PET.
    Hoh, CK
    Figlin, RA
    Belldegrun, A
    Moon, DH
    Franklin, J
    Phelps, ME
    Maddahi, J
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 621 - 621
  • [2] The prognostic value of 18F-FDG PET imaging for patients with nonsmall cell lung carcinoma.
    Min, JJ
    Chung, JK
    Park, JM
    Kim, BT
    Paeng, JC
    Yeo, JS
    Lee, DS
    Lee, KH
    Lee, MC
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 299P - 299P
  • [3] FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma.
    Ferdinandus, Justin
    Maric, Ines
    Darr, Christopher
    Kesch, Claudia
    Hilser, Thomas
    Fendler, Wolfgang Peter
    Herrmann, Ken
    Hadaschik, Boris A.
    Gruenwald, Viktor
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
    Alongi, Pierpaolo
    Picchio, Maria
    Zattoni, Fabio
    Spallino, Marianna
    Gianolli, Luigi
    Saladini, Giorgio
    Evangelista, Laura
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (03) : 464 - 473
  • [5] Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
    Pierpaolo Alongi
    Maria Picchio
    Fabio Zattoni
    Marianna Spallino
    Luigi Gianolli
    Giorgio Saladini
    Laura Evangelista
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 464 - 473
  • [6] Incremental value of 18F-FDG PET-CECT over conventional imaging in evaluation of Gall Bladder Carcinoma.
    Singh, P.
    Singhal, T.
    Kumar, P.
    Parida, G.
    Emerson, R.
    Bishnoi, K.
    Rehman, A.
    Kandula, K.
    Agrawal, K.
    Patro, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S493 - S494
  • [7] Accuracy of whole body FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon, DH
    Hoh, CK
    Silverman, DS
    Glaspy, JA
    Phelps, ME
    Maddahi, J
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 386 - 386
  • [8] Staging of malignant melanoma:: Cost effectiveness of whole-body FDG PET vs. conventional imaging
    Steinert, HC
    Ullrich, SP
    Guillong, E
    Böni, R
    von Schulthess, GK
    Dummer, R
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 94P - 94P
  • [9] Diagnostic utility of FDG PET in metastatic and recurrent renal cell carcinoma.
    Jadvar, H
    Kherbache, H
    Conti, P
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 404P - 404P
  • [10] Renal cell carcinoma. Drug therapy and prognostic models
    Reiter, M. A.
    Kurosch, M.
    Haferkamp, A.
    UROLOGE, 2015, 54 (05): : 735 - 748
12345